Neoplasia Clinical Trials

6 recruiting

Neoplasia Trials at a Glance

79 actively recruiting trials for neoplasia are listed on ClinicalTrialsFinder across 6 cities in 25 countries. The largest study group is Not Applicable with 24 trials, with the heaviest enrollment activity in Houston, Shanghai, and Hangzhou. Lead sponsors running neoplasia studies include Peking Union Medical College Hospital, Women's Hospital School Of Medicine Zhejiang University, and Changhai Hospital.

Browse neoplasia trials by phase

Treatments under study

About Neoplasia Clinical Trials

Looking for clinical trials for Neoplasia? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Neoplasia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Neoplasia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 79 trials

Recruiting

Familial Investigations of Childhood Cancer Predisposition

Hereditary Breast and Ovarian CancerHodgkin LymphomaAdrenocortical Carcinoma+30 more
St. Jude Children's Research Hospital1,500 enrolled1 locationNCT03050268
Recruiting
Phase 1

Lopinavir/Ritonavir in PLWH With High-Grade AIN

High-Grade Anal Intraepithelial Neoplasia
University of Wisconsin, Madison21 enrolled1 locationNCT05334004
Recruiting
Phase 2Phase 3

Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors

Primary HyperparathyroidismParathyroid CancerMultiple Endocrine Neoplasias+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)193 enrolled1 locationNCT07444723
Recruiting
Not Applicable

Digital Telecytology for Triage of HPV-Positive Women in Cameroon

Human Papillomavirus InfectionCervical Cancer Screening MethodsCervical Intraepithelial Neoplasia Grade 2 (CIN2)
University Hospital, Geneva1,800 enrolled2 locationsNCT07550010
Recruiting

Endometrial Cancer Vaginal Fluid Specimen Collection Study

Endometrial CancerEndometrial Intraepithelial NeoplasiaAtypical Endometrial Hyperplasia+2 more
Exact Sciences Corporation4,200 enrolled1 locationNCT07544680
Recruiting
Phase 1

First-in-Human Assessment of Safety, Biodistribution and Pharmacokinetics of 18F-Fluoro-1-Naphthol (18F-4FN) for PET Imaging

Endocrine Neoplasia
M.D. Anderson Cancer Center55 enrolled1 locationNCT05335811
Recruiting
Not Applicable

Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals

Risk of Breast CancerRisk of Gynaecological CancerRisk of Colorectal Cancer+14 more
Gustave Roussy, Cancer Campus, Grand Paris5,909 enrolled1 locationNCT06907095
Recruiting
Not Applicable

Feasibility Study of Ocular Surface Squamous Neoplasia Surgical Excision in People Living With HIV in Sub-Saharan Africa

HPVOcular Surface Squamous Neoplasia
AIDS Malignancy Consortium84 enrolled1 locationNCT04704648
Recruiting
Not Applicable

Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule

Hydatidiform MoleGestational Trophoblastic Neoplasia
Women's Hospital School Of Medicine Zhejiang University30 enrolled1 locationNCT03785574
Recruiting
Not Applicable

Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer

I) Atypical Squamous Cells of Undetermined Significance (ASC-US)II) Atypical Glandular Cells of Uncertain Significance (AGUS)III) Cervical Intraepithelial Neoplasia (CIN), CIN-1, CIN-2, CIN-3+3 more
Timser SAPI de CV558 enrolled1 locationNCT07480902
Recruiting
Not Applicable

Point of Care - Triage and Treatment for Cervical Pre-cancer

Cervical Intraepithelial NeoplasiaHuman Papillomavirus InfectionCervical Precancer
Basic Health International, Inc.5,000 enrolled1 locationNCT07461818
Recruiting
Phase 2

Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia

Cervical Intraepithelial NeoplasiaCervical Squamous Cell Carcinoma In SituCervical Squamous Intraepithelial Neoplasia 2
Jonsson Comprehensive Cancer Center25 enrolled1 locationNCT04712851
Recruiting
Not Applicable

A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.

HPVCIN - Cervical Intraepithelial NeoplasiaCIN 1+2 more
Papillex Inc.60 enrolled1 locationNCT06979180
Recruiting

The Radiation Oncology Registry and Biosample Repository

Neoplasia
Abramson Cancer Center at Penn Medicine8,000 enrolled4 locationsNCT01577251
Recruiting
Not Applicable

IDENTIFY Study: Natural History of Maternal Neoplasia

Maternal Neoplasia
National Human Genome Research Institute (NHGRI)365 enrolled1 locationNCT04049604
Recruiting
Phase 2

Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States

Suspected or Known Squamous Cell NeoplasiaPrior History of Squamous Cell Dysplasia and /or Neoplasia
Baylor College of Medicine200 enrolled4 locationsNCT06435286
Recruiting
Phase 4

A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)

Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)Human Papillomavirus (HPV) InfectionsHigh-risk HPV+1 more
Miquel Angel Pavon Ribas69 enrolled1 locationNCT05334706
Recruiting
Not Applicable

REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)

NeoplasiaOsteoporosisOsteogenesis Imperfecta+1 more
Meyer Children's Hospital IRCCS100 enrolled1 locationNCT07412782
Recruiting
Phase 2

Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia

Gestational Trophoblastic Neoplasia
Peking Union Medical College Hospital70 enrolled1 locationNCT05139095
Recruiting
Not Applicable

Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer

Uterine Cervical NeoplasmsCervical CancersCervical Intraepithelial Neoplasia+1 more
DL Analytics10,000 enrolled1 locationNCT06815939